Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen–induced allergic rhinitis in an allergen-exposure unit
- 1 June 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 109 (6) , 956-961
- https://doi.org/10.1067/mai.2002.124657
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitisAllergy, 2001
- Allergy and Allergic DiseasesNew England Journal of Medicine, 2001
- Efficacy and Tolerability of Once-Daily 5mg Desloratadine, an H1-Receptor Antagonist, in Patients with Seasonal Allergic RhinitisClinical Drug Investigation, 2001
- MANAGEMENT OF ALLERGIC RHINITISImmunology and Allergy Clinics of North America, 2000
- Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trialsBMJ, 1998
- Effect of H1and H2Antagonists on Nasal Symptoms and Mediator Release in Atopic Patients after Nasal Allergen Challenge during the Pollen SeasonActa Oto-Laryngologica, 1996
- Clinical studies with cetirizine in allergic rhinitis and chronic urticariaAllergy, 1995
- Effects of H1‐receptor antagonists on nasal obstruction in atopic patientsAllergy, 1993
- Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humansClinical and Experimental Allergy, 1986
- Adrenoceptors in the Control of Human Nasal Mucosal Blood FlowAnnals of Otology, Rhinology & Laryngology, 1984